NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Clinical trials for NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS) explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS) trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Blood test aims to spare lung cancer patients from unnecessary chemotherapy
Disease control Not yet recruitingThis study is testing a new blood test to help doctors choose the best first treatment for advanced lung cancer. It aims to identify patients who can safely receive immunotherapy alone, which can provide long-lasting control, while avoiding the risk of rapid tumor growth that som…
Matched conditions: NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Disease control
Last updated Apr 02, 2026 02:11 UTC
-
New hope for advanced lung cancer patients in global drug trial
Disease control Not yet recruitingThis global study is testing whether adding an experimental drug called EIK1001 to standard immunotherapy and chemotherapy can better control advanced lung cancer. It will involve 750 adults with stage 4 non-small cell lung cancer who have not yet received treatment for their adv…
Matched conditions: NON SMALL CELL LUNG CANCER (SQUAMOUS OR NON SQUAMOUS)
Phase: PHASE2, PHASE3 • Sponsor: Eikon Therapeutics • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC